创新药技术转移在其产业化过程中的策略研究
发布时间：2018-09-09 13:37
【摘要】：医药企业内部的自主研发很难满足其可持续发展的需求,高校和研究机构则是创新药的源头,但他们不擅长产业化,所以,创新药的技术转移成了产业化过程中不可缺少的一个环节。创新药的产业化几乎是所有医药企业战略规划的最高目标,医药企业为了不断地更新其产品线,因自主研发无法满足市场需求,创新药技术转移就成了医药产业化过程中的必由之路。本文介绍了创新药的研发流程和产业化的发展过程,解释了其风险高、成本高、时间长的复杂性和不确定性的特点,本文通过对医药产业的发展现状和发展趋势的介绍,展现出了创新药研发在医药产业中的重要性和必要性。技术转移在创新药产业化过程中的作用也显得尤为重要,其中,知识产权保护是技术转移的核心,同时,也强调了创新药的市场潜力和价值研究的重要性,以及和已上市药品的比较优势,项目本身的可行性程度,还有引进项目方的产品线特点和设备优势等等。在大量文献研究的基础上,本文综合了目前创新药技术转移的各环节,还增加了一些创新性的研究方式和评估手段,针对技术转移的双方进行优劣势分析和项目本身的全方位评估,以降低产业化过程中的风险。本文还具体分析了影响技术转移的相关因素,通过专家论证,文献研究,国内外政策对比,典型实例研究,包括国外项目向国内转移,国外和国内项目的内部转移以及国内项目向国外转移或授权等各种情况,通过对成功经验的吸取和失败教训的总结,阐述了这些影响因素的应对方式和转移过程中的应对策略。
[Abstract]:Independent R & D within pharmaceutical enterprises is very difficult to meet their sustainable development needs. Universities and research institutions are the source of innovative drugs, but they are not good at industrialization, so, The technology transfer of innovative medicine has become an indispensable link in the process of industrialization. The industrialization of innovative drugs is the highest goal of almost all pharmaceutical enterprises in their strategic planning. In order to continuously update their product lines, pharmaceutical enterprises cannot meet the market demand through independent research and development. Innovative drug technology transfer has become the only way in the process of pharmaceutical industrialization. This paper introduces the R & D process of innovative drugs and the development process of industrialization, and explains the characteristics of high risk, high cost, long time complexity and uncertainty. It shows the importance and necessity of the research and development of innovative drugs in the pharmaceutical industry. The role of technology transfer in the industrialization of innovative drugs is particularly important, in which intellectual property protection is the core of technology transfer, and the importance of market potential and value research of innovative drugs is also emphasized. As well as the comparative advantages with the listed drugs, the feasibility of the project itself, as well as the product line characteristics and equipment advantages of the imported project side and so on. On the basis of a large number of literature studies, this paper synthesizes all aspects of the technology transfer of innovative drugs at present, and adds some innovative research methods and evaluation methods. In order to reduce the risk in the process of industrialization, the advantages and disadvantages of the two sides of technology transfer and the overall evaluation of the project itself are analyzed. This paper also analyzes the relevant factors affecting technology transfer, through expert demonstration, literature research, domestic and foreign policy comparison, typical case studies, including the transfer of foreign projects to the domestic. The internal transfer of foreign and domestic projects and the transfer or authorization of domestic projects to foreign countries are discussed in this paper. By summing up the successful experiences and the lessons learned from failures, the coping methods of these influencing factors and the coping strategies in the transfer process are expounded.
【学位授予单位】：华中科技大学
【学位级别】：硕士
【学位授予年份】：2015
【分类号】：F426.72
[Abstract]:Independent R & D within pharmaceutical enterprises is very difficult to meet their sustainable development needs. Universities and research institutions are the source of innovative drugs, but they are not good at industrialization, so, The technology transfer of innovative medicine has become an indispensable link in the process of industrialization. The industrialization of innovative drugs is the highest goal of almost all pharmaceutical enterprises in their strategic planning. In order to continuously update their product lines, pharmaceutical enterprises cannot meet the market demand through independent research and development. Innovative drug technology transfer has become the only way in the process of pharmaceutical industrialization. This paper introduces the R & D process of innovative drugs and the development process of industrialization, and explains the characteristics of high risk, high cost, long time complexity and uncertainty. It shows the importance and necessity of the research and development of innovative drugs in the pharmaceutical industry. The role of technology transfer in the industrialization of innovative drugs is particularly important, in which intellectual property protection is the core of technology transfer, and the importance of market potential and value research of innovative drugs is also emphasized. As well as the comparative advantages with the listed drugs, the feasibility of the project itself, as well as the product line characteristics and equipment advantages of the imported project side and so on. On the basis of a large number of literature studies, this paper synthesizes all aspects of the technology transfer of innovative drugs at present, and adds some innovative research methods and evaluation methods. In order to reduce the risk in the process of industrialization, the advantages and disadvantages of the two sides of technology transfer and the overall evaluation of the project itself are analyzed. This paper also analyzes the relevant factors affecting technology transfer, through expert demonstration, literature research, domestic and foreign policy comparison, typical case studies, including the transfer of foreign projects to the domestic. The internal transfer of foreign and domestic projects and the transfer or authorization of domestic projects to foreign countries are discussed in this paper. By summing up the successful experiences and the lessons learned from failures, the coping methods of these influencing factors and the coping strategies in the transfer process are expounded.
【学位授予单位】：华中科技大学
【学位级别】：硕士
【学位授予年份】：2015
【分类号】：F426.72
【参考文献】
相关期刊论文 前10条
1 程永浩;;创新药物技术转移模式探索[J];医药导报;2014年08期
2 袁源;骆国军;周静;周蓉;;药品研发中的风险控制[J];中国药事;2014年06期
3 程永浩;;创新药物技术转移中的知识产权保护策略[J];中国科技产业;2014年06期
4 曹晓瑞;毕军;黄民;;国内外药品技术转让相关制度对比简析[J];中国医药工业杂志;2014年05期
5 闫娟娟;;基于知识共享视角的药物研发过程研究[J];医药导报;2014年04期
6 吴捷;曹阳;;基于价值链视角对我国制药企业商业模式分类研究[J];上海医药;2014年05期
7 章立;朱海亮;;国际生命科技产业发展对我国的启示[J];现代管理科学;2014年03期
8 尤璐;冯国忠;;我国医药企业技术创新SWOT分析[J];现代商贸工业;2014年04期
9 张磊;王艳霞;;全球创新药研发趋势与重点研发领域[J];中国药业;2014年02期
10 袁丽;杨悦;;国际创新药物研发现状及未来发展趋势[J];中国新药杂志;2013年18期
相关博士学位论文 前1条
1 石忠国;生物技术产业区域竞争力评价与培育策略[D];电子科技大学;2012年
相关硕士学位论文 前4条
1 亓s，
本文编号：2232538
本文链接：https://www.wllwen.com/qiyeguanlilunwen/2232538.html
